Who was studied, and how
One number in the abstract
Where each one falls
Where it lands on the map
What it changes
Among 11 other studies
110people with dyslipidemia, in this paper
The trial randomly assignedassigned by chance
atorvastatin
no statins
Reported higher SCD-free survival, no range given2.3×
randomisedthe abstract, start to end
SCD-free survival was 2.3-times higher in the statin …
← favours treatmentfavours comparator →
could be chanceNo interval given · direction only, strength unknown
SCD-free survivalatorvastatin vs no statins
RR 2.3
StatinsAll-cause mortality
Statins × all-cause mortalityhelps?mixed
unlikelylikely
0.500.48 without it
← favours comparatorfavours treatment →
1 / 6